Syndax Pharmaceuticals Inc - SNDX

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Feb 10, 2026 Chief Executive Officer S D 17,159.0 21.028 360,819.45 491,690.0 View
Feb 10, 2026 Chief Financial Officer S D 3,410.0 21.028 71,705.48 140,429.0 View
Feb 06, 2026 Chief Executive Officer A A 440,000.0 20.43 8,989,200.0 440,000.0 View
Feb 06, 2026 Chief Executive Officer S D 7,412.0 20.62 152,835.44 508,849.0 View
Feb 06, 2026 Chief Executive Officer A A 144,600.0 0.0 0.0 516,261.0 View
Feb 06, 2026 Chief Executive Officer A A 73,000.0 0.0 0.0 371,661.0 View
Feb 06, 2026 Chief Financial Officer A A 118,000.0 20.43 2,410,740.0 118,000.0 View
Feb 06, 2026 Chief Financial Officer S D 2,082.0 20.62 42,930.84 143,839.0 View
Feb 06, 2026 Chief Financial Officer A A 30,750.0 0.0 0.0 145,921.0 View
Feb 06, 2026 Chief Financial Officer A A 21,500.0 0.0 0.0 115,171.0 View
Feb 06, 2026 Chief Financial Officer J A 1,219.0 8.48 10,337.12 93,671.0 View
Feb 06, 2026 A A 24,000.0 0.0 0.0 114,000.0 View
Feb 06, 2026 A A 24,000.0 0.0 0.0 103,000.0 View
Feb 06, 2026 Head of R&D, CMO A A 144,700.0 20.43 2,956,221.0 144,700.0 View
Feb 06, 2026 Head of R&D, CMO A A 36,000.0 0.0 0.0 95,165.0 View
Feb 06, 2026 Head of R&D, CMO A A 24,000.0 0.0 0.0 59,165.0 View
Feb 06, 2026 A A 48,000.0 0.0 0.0 239,763.0 View
Feb 06, 2026 A A 24,000.0 0.0 0.0 49,000.0 View
Feb 06, 2026 A A 24,000.0 0.0 0.0 124,000.0 View
Feb 06, 2026 A A 24,000.0 0.0 0.0 114,000.0 View
Dec 01, 2025 Chief Financial Officer G D 1,224.0 0.0 0.0 92,452.0 View